For patients with Parkinson disease on levodopa therapy, patient-rated quality of life is similar for those receiving adjuvant therapy with dopamine agonists compared with dopamine reuptake inhibitors (DRIs); and among DRIs, ...
Dec 29, 2021
0
18
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have ...
Apr 11, 2021
0
152
Breathe in, breathe out. That's how easy it is for SARS-CoV-2, the virus that causes COVID-19, to enter your nose. And though remarkable progress has been made in developing intramuscular vaccines against SARS-CoV- 2, such ...
Sep 15, 2021
0
589
Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The study results are published today ...
Jun 20, 2020
0
168
A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results ...
Jul 14, 2020
5
226
As the number of novel coronavirus infections rises daily across the globe, strategies for developing a safe and effective vaccine are rapidly moving forward.
Mar 16, 2020
0
416
An older woman's oestrogen levels may be linked to her chances of dying from COVID-19, with higher levels of the hormone seemingly protective against severe infection, suggests research published in the open access journal ...
Feb 14, 2022
0
28
San Diego State University researchers at the Donald P. Shiley BioScience Center may have found the secret to helping the immune system fight off the flu before it gets you sick.
Jul 6, 2012
0
0
An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new treatment, according to research by a Georgia Health Sciences University graduate student.
Sep 26, 2011
0
0
New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range of variants producing potent antibody responses against current and past strains, and may even ...
